Macquarie Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.4M | Buy |
25,387
+16,045
| +172% | +$9M | 0.06% | 240 |
|
|
2026
Q1 | $5.25M | Sell |
9,342
-7,511
| -45% | -$4.82M | 0.03% | 344 |
|
|
2025
Q4 | $11.4M | Sell |
16,853
-509,777
| -97% | -$347M | 0.05% | 256 |
|
|
2025
Q3 | $336M | Sell |
526,630
-75,014
| -12% | -$45.5M | 0.39% | 29 |
|
|
2025
Q2 | $323M | Sell |
601,644
-53,757
| -8% | -$25.7M | 0.4% | 27 |
|
|
2025
Q1 | $275M | Buy |
655,401
+173,766
| +36% | +$75.5M | 0.34% | 46 |
|
|
2024
Q4 | $198M | Buy |
481,635
+37,438
| +8% | +$16.4M | 0.24% | 86 |
|
|
2024
Q3 | $224M | Buy |
444,197
+37,618
| +9% | +$18.3M | 0.24% | 82 |
|
|
2024
Q2 | $198M | Buy |
406,579
+9,507
| +2% | +$4.77M | 0.23% | 100 |
|
|
2024
Q1 | $214M | Buy |
397,072
+5,128
| +1% | +$2.8M | 0.24% | 94 |
|
|
2023
Q4 | $218M | Buy |
391,944
+47,708
| +14% | +$22.4M | 0.25% | 80 |
|
|
2023
Q3 | $151M | Buy |
344,236
+326,945
| +1,891% | +$163M | 0.19% | 135 |
|
|
2023
Q2 | $8.68M | Sell |
17,291
-1,728
| -9% | -$828K | 0.01% | 828 |
|
|
2023
Q1 | $9.51M | Sell |
19,019
-7,628
| -29% | -$3.65M | 0.01% | 813 |
|
|
2022
Q4 | $10.9M | Buy |
26,647
+2,078
| +8% | +$807K | 0.01% | 814 |
|
|
2022
Q3 | $8.01M | Buy |
24,569
+18,001
| +274% | +$6.61M | 0.01% | 881 |
|
|
2022
Q2 | $2.3M | Buy |
6,568
+48
| +0.7% | +$19.6K | ﹤0.01% | 1251 |
|
|
2022
Q1 | $3.57K | Buy |
6,520
+49
| +0.8% | +$25.8K | ﹤0.01% | 1206 |
|
|
2021
Q4 | $4.26M | Sell |
6,471
-42,944
| -87% | -$27M | ﹤0.01% | 1154 |
|
|
2021
Q3 | $30.7M | Buy |
49,415
+39,432
| +395% | +$26.5M | 0.03% | 648 |
|
|
2021
Q2 | $6.3M | Buy |
9,983
+7,627
| +324% | +$4.21M | 0.01% | 1059 |
|
|
2021
Q1 | $1.15M | Buy |
2,356
+65
| +3% | +$32.6K | ﹤0.01% | 1357 |
|
|
2020
Q4 | $1.15M | Buy |
2,291
+380
| +20% | +$170K | ﹤0.01% | 1277 |
|
|
2020
Q3 | $752K | Buy |
1,911
+513
| +37% | +$190K | ﹤0.01% | 1304 |
|
|
2020
Q2 | $462K | Sell |
1,398
-1,567
| -53% | -$454K | ﹤0.01% | 1365 |
|
|
2020
Q1 | $718K | Buy |
2,965
+34
| +1% | +$8.87K | ﹤0.01% | 1180 |
|
|
2019
Q4 | $766K | Buy |
2,931
+128
| +5% | +$33.7K | ﹤0.01% | 1309 |
|
|
2019
Q3 | $762K | Sell |
2,803
-545
| -16% | -$152K | ﹤0.01% | 1290 |
|
|
2019
Q2 | $922K | Sell |
3,348
-3,777
| -53% | -$931K | ﹤0.01% | 1240 |
|
|
2019
Q1 | $1.59M | Hold |
7,125
| – | – | ﹤0.01% | 1056 |
|
|
2018
Q4 | $1.32M | Sell |
7,125
-300
| -4% | -$61.5K | ﹤0.01% | 1071 |
|
|
2018
Q3 | $1.85M | Buy |
7,425
+195
| +3% | +$47.3K | ﹤0.01% | 1023 |
|
|
2018
Q2 | $1.57M | Sell |
7,230
-15,706
| -68% | -$3.24M | ﹤0.01% | 1063 |
|
|
2018
Q1 | $4.39M | Buy |
22,936
+20,036
| +691% | +$3.7M | 0.01% | 787 |
|
|
2017
Q4 | $443K | Sell |
2,900
-35,100
| -92% | -$5.52M | ﹤0.01% | 1483 |
|
|
2017
Q3 | $5.91M | Buy |
38,000
+2,500
| +7% | +$395K | 0.01% | 718 |
|
|
2017
Q2 | $5.73M | Sell |
35,500
-2,975
| -8% | -$483K | 0.01% | 713 |
|
|
2017
Q1 | $5.95M | Sell |
38,475
-27,125
| -41% | -$3.74M | 0.01% | 713 |
|
|
2016
Q4 | $7.69M | Sell |
65,600
-13,600
| -17% | -$1.55M | 0.01% | 650 |
|
|
2016
Q3 | $8.93M | Sell |
79,200
-76,800
| -49% | -$8.09M | 0.02% | 627 |
|
|
2016
Q2 | $14.5M | Buy |
+156,000
| New | +$13.4M | 0.01% | 637 |
|
|
2014
Q4 | – | Sell |
-20,400
| Closed | -$1.2M | – | 1587 |
|
|
2014
Q3 | $1.2M | Sell |
20,400
-17,000
| -45% | -$1.07M | ﹤0.01% | 1132 |
|
|
2014
Q2 | $2.5M | Sell |
37,400
-13,800
| -27% | -$877K | 0.01% | 970 |
|
|
2014
Q1 | $3.11M | Buy |
51,200
+1,400
| +3% | +$83.4K | 0.01% | 852 |
|
|
2013
Q4 | $2.65M | Hold |
49,800
| – | – | ﹤0.01% | 879 |
|
|
2013
Q3 | $2.48M | Hold |
49,800
| – | – | ﹤0.01% | 852 |
|
|
2013
Q2 | $2.24M | Buy |
+49,800
| New | +$2.18M | ﹤0.01% | 866 |
|
Other funds holding IDXX
Macquarie Group's IDXX Position: Q2 2026 in Review
Macquarie Group increased its Idexx Laboratories (IDXX) stake by 172% in Q2 2026, buying an estimated $9M and bringing the position to 25,387 shares worth $13.4M. The position accounts for 0.06% of the portfolio, ranked #240.
Macquarie Group first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $336M in Q3 2025. 1,294 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Macquarie Group held 25,387 shares of Idexx Laboratories worth $13.4M as of Q2 2026.
- Macquarie Group bought 16,045 Idexx Laboratories shares in Q2 2026, an estimated $9M.
- Idexx Laboratories made up 0.06% of Macquarie Group's portfolio in Q2 2026, its #240 holding.
- Macquarie Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
- Macquarie Group's Idexx Laboratories position peaked at $336M in Q3 2025.
- 1,294 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.